Clinical Trial Update: HBsAg Seroclearance in Adults With HBV Related Liver Fibrosis After Receiving Combined Therapy of Peg-IFN and Tenofovir. [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update reports HBsAg seroclearance in adults with HBV-related liver fibrosis receiving a combined therapy of Pegylated interferon and t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Hepatitis with Liver Fibrosis

Drugs mentioned

• PEG-IFNα (pegylated interferon alfa)
• Tenofovir (Tenofovir)

Snippet

Sponsor: Third Affiliated Hospital, Sun Yat-Sen University | Conditions: Liver Fibrosis | Phase 4 | Status: UNKNOWN